"A service of Geisinger Medical Center, Geisinger Radiation Oncology Pottsville, is a 6,750 square-foot facility offering radiation therapy as part or the only type of treatment for both benign and cancerous tumors. Conventional radiation treatments, Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) are available to patients who choose radiation therapy for their treatment."

During the past decade, Geisinger Cancer Services-Pottsville conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 53 clinical trials were completed, i.e. on average, 47.7% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 45 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geisinger Cancer Services-Pottsville" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "NRG Oncology" with 15 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Cancer Services-Pottsville" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Geisinger Cancer Services-Pottsville" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials), "HER2/Neu Negative" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Geisinger Cancer Services-Pottsville" in a lesser frequency.

Most popular intervention types in "Geisinger Cancer Services-Pottsville" are "Drug" (110 trials), "Other" (103 trials), "Biological" (57 trials), "Procedure" (32 trials) and "Radiation" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (44 trials), "Questionnaire Administration" (27 trials), "Computed Tomography" (20 trials) and "Cisplatin" (19 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Cancer Services-Pottsville" are 118 trials for "All" genders, 21 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Geisinger Cancer Services-Pottsville". undefined are not yet recruiting, 38 are recruiting, 68 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Geisinger Cancer Services-Pottsville, 6 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Cancer Services-Pottsville, 4 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".